Archive for category Books

[Booklet] Parenting after brain injury – PDF

by Dr Alex Goody

Image result for Parenting after brain injury

This booklet has been written to help those parents
who have had a brain injury understand how their injury
has affected them in their role as a parent.

 

, ,

Leave a comment

[Abstract + References] Epilepsy and Anticonvulsant Therapy in Brain Tumor Patients – Book Chapter

Book Chapter

Authors: Sylvia C. Kurz, David Schiff, Patrick Y. Wen

Abstract

Seizures are common in patients with brain tumors and may have a significant impact on quality of life. The actual seizure risk varies based on tumor histology and tumor location. Seizures are most common in patients with glioneuronal tumors and temporal, insular, or frontal lobe tumor location. Antiepileptic drug therapy is indicated in patients with a history of seizure, and the choice of symptomatic treatment should follow the principles of treatment for focal symptomatic epilepsy. In general, antiepileptic drugs that interact with the hepatic CYP450 co-enzymes should be avoided in brain tumor patients if possible due to potential drug-chemotherapy interactions. Levetiracetam represents the antiepileptic drug of choice in patients with brain tumors and has been demonstrated to be efficacious and is well tolerated in brain tumor patients. Lacosamide is an alternative anticonvulsant agent with increasing experience supporting its efficacy and favorable side effect profile.

References

  1. 1.
    Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34:98–102PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Herman ST (2002) Epilepsy after brain insult: targeting epileptogenesis. Neurology 59:S21–S26PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    De Santis A, Villani R, Sinisi M, Stocchetti N, Perucca E (2002) Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43:175–182PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Southwell DG, Garcia PA, Berger MS, Barbaro NM, Chang EF (2012) Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 70:1406–1413; discussion 1413–1404PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Chang EF, Christie C, Sullivan JE et al (2010) Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J Neurosurg Pediatr 5:123–130PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Tomita T, Volk JM, Shen W, Pundy T (2016) Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences. Childs Nerv Syst 32:1839–1848PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Pallud J, Audureau E, Blonski M et al (2014) Epileptic seizures in diffuse low-grade gliomas in adults. Brain 137:449–462PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–235PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717–724PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Flanigan PM, Jahangiri A, Kuang R et al (2017) Improved survival with decreased wait time to surgery in glioblastoma patients presenting with seizure. Neurosurgery 81(5):824–833PubMedPubMedCentralGoogle Scholar
  11. 11.
    Toledo M, Sarria-Estrada S, Quintana M et al (2017) Epileptic features and survival in glioblastomas presenting with seizures. Epilepsy Res 130:1–6PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW (2016) Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg 124:1552–1561PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Lieu AS, Howng SL (2000) Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 38:45–52PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W (2002) [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna]. Wien Klin Wochenschr 114:911–916Google Scholar
  15. 15.
    Wu A, Weingart JD, Gallia GL et al (2017) Risk factors for preoperative seizures and loss of seizure control in patients undergoing surgery for metastatic brain tumors. World Neurosurg 104:120–128PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Lynam LM, Lyons MK, Drazkowski JF et al (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109:634–638PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    You G, Sha ZY, Yan W et al (2012) Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol 14:230–241PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Lee JW, Wen PY, Hurwitz S et al (2010) Morphological characteristics of brain tumors causing seizures. Arch Neurol 67:336–342PubMedPubMedCentralGoogle Scholar
  19. 19.
    Englot DJ, Chang EF, Vecht CJ (2016) Epilepsy and brain tumors. Handb Clin Neurol 134:267–285PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Fish DR, Spencer SS (1995) Clinical correlations: MRI and EEG. Magn Reson Imaging 13:1113–1117PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Spencer S, Huh L (2008) Outcomes of epilepsy surgery in adults and children. Lancet Neurol 7:525–537PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Schaller B (2005) Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis. Acta Neurol Scand 111:75–83PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Wolf HK, Roos D, Blumcke I, Pietsch T, Wiestler OD (1996) Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 91:376–384PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Beaumont A, Whittle IR (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 142:1–15CrossRefGoogle Scholar
  25. 25.
    Yuen TI, Morokoff AP, Bjorksten A et al (2012) Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology 79:883–889PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Rosati A, Poliani PL, Todeschini A et al (2013) Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme. Neuro Oncol 15:618–625PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Pallud J, Capelle L, Huberfeld G (2013) Tumoral epileptogenicity: how does it happen? Epilepsia 54(Suppl 9):30–34PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Aronica E, Yankaya B, Jansen GH et al (2001) Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol 27:223–237PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Bateman DE, Hardy JA, McDermott JR, Parker DS, Edwardson JA (1988) Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy. Neurol Res 10:112–114PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Chen H, Judkins J, Thomas C et al (2017) Mutant IDH1 and seizures in patients with glioma. Neurology 88:1805–1813PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD (2004) An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol 107:381–388PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Danfors T, Ribom D, Berntsson SG, Smits A (2009) Epileptic seizures and survival in early disease of grade 2 gliomas. Eur J Neurol 16:823–831PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Berendsen S, Varkila M, Kroonen J et al (2016) Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol 18:700–706PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Buckner JC, Shaw EG, Pugh SL et al (2016) Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med 374:1344–1355PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Cairncross JG, Wang M, Jenkins RB et al (2014) Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 32:783–790PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Stockhammer F, Misch M, Helms HJ et al (2012) IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 21:194–197PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Liubinas SV, D’Abaco GM, Moffat BM et al (2014) IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia 55:1438–1443PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Neal A, Kwan P, O’Brien TJ, Buckland ME, Gonzales M, Morokoff A (2017) IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. Epilepsy Behav 78:30–36PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Chaichana KL, Parker SL, Olivi A, Quinones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg 111:282–292PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Sheth RD (2002) Adolescent issues in epilepsy. J Child Neurol 17(Suppl 2):2S23–22S27PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Batchelor TT, Byrne TN (2006) Supportive care of brain tumor patients. Hematol Oncol Clin North Am 20:1337–1361PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Auriel E, Landov H, Blatt I et al (2009) Quality of life in seizure-free patients with epilepsy on monotherapy. Epilepsy Behav 14:130–133PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Giulioni M, Galassi E, Zucchelli M, Volpi L (2005) Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children. J Neurosurg 102:288–293PubMedGoogle Scholar
  48. 48.
    Giulioni M, Gardella E, Rubboli G et al (2006) Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J Clin Neurosci 13:529–535PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Giulioni M, Rubboli G, Marucci G et al (2009) Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg 111:1275–1282PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Bonney PA, Glenn CA, Ebeling PA et al (2015) Seizure freedom rates and prognostic indicators after resection of gangliogliomas: a review. World Neurosurg 84:1988–1996PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Bonney PA, Boettcher LB, Conner AK et al (2016) Review of seizure outcomes after surgical resection of dysembryoplastic neuroepithelial tumors. J Neurooncol 126:1–10PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Englot DJ, Han SJ, Berger MS, Barbaro NM, Chang EF (2012) Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery 70:921–928; discussion 928PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Bonney PA, Boettcher LB, Burks JD et al (2017) Rates of seizure freedom after surgical resection of diffuse low-grade gliomas. World Neurosurg 106:750–756PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Chaichana KL, Pendleton C, Zaidi H et al (2013) Seizure control for patients undergoing meningioma surgery. World Neurosurg 79:515–524PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Chen WC, Magill ST, Englot DJ et al (2017) Factors associated with pre- and postoperative seizures in 1033 patients undergoing supratentorial meningioma resection. Neurosurgery 81(2):297–306PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Ruda R, Magliola U, Bertero L et al (2013) Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol 15:1739–1749PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Rogers LR, Morris HH, Lupica K (1993) Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 43:1599–1601PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Chalifoux R, Elisevich K (1996) Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors. Stereotact Funct Neurosurg 67:169–182PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Taphoorn MJ, Stupp R, Coens C et al (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937–944PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Reijneveld JC, Taphoorn MJ (2015) Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol 17:924–934PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Kaloshi G, Benouaich-Amiel A, Diakite F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68:1831–1836PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Pace A, Vidiri A, Galie E et al (2003) Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 14:1722–1726PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Koekkoek JA, Dirven L, Heimans JJ et al (2015) Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry 86:366–373PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Soffietti R, Ruda R, Bradac GB, Schiffer D (1998) PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 43:1066–1073PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Lebrun C, Fontaine D, Bourg V et al (2007) Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol 14:391–398PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Frenay MP, Fontaine D, Vandenbos F, Lebrun C (2005) First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas. Eur J Neurol 12:685–690PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Wu AS, Trinh VT, Suki D et al (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118:873–883PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Franceschetti S, Binelli S, Casazza M et al (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wein) 103:47–51CrossRefGoogle Scholar
  69. 69.
    Forsyth PA, Weaver S, Fulton D et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30:106–112PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Dewan MC, White-Dzuro GA, Brinson PR et al (2017) The influence of perioperative seizure prophylaxis on seizure rate and hospital quality metrics following glioma resection. Neurosurgery 80:563–570PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 58:672–677PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557–564PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Dewan MC, Thompson RC, Kalkanis SN, Barker FG II, Hadjipanayis CG (2017) Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS section on tumors survey. J Neurosurg 126:1772–1778PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489–1494PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Pulman J, Greenhalgh J, Marson AG (2013) Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2:CD007286Google Scholar
  76. 76.
    Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA (1996) Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 5:291–298PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Weston J, Greenhalgh J, Marson AG (2015) Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 3:CD007286Google Scholar
  78. 78.
    Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Soffietti R, Baumert BG, Bello L et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO task force. Eur J Neurol 17:1124–1133PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Glauser T, Ben-Menachem E, Bourgeois B et al (2013) Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54:551–563PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Crepeau AZ, Sirven JI (2017) Management of adult onset seizures. Mayo Clin Proc 92:306–318PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Gilbert MR, Supko JG, Batchelor T et al (2003) Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma. Clin Cancer Res 9:2940–2949PubMedPubMedCentralGoogle Scholar
  83. 83.
    Maschio M, Albani F, Baruzzi A et al (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 80:97–100PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404–409PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255–260PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Neef C, de Voogd-van der Straaten I (1988) An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 43:372–375PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Ruegg S (2002) Dexamethasone/phenytoin interactions: neurooncological concerns. Swiss Med Wkly 132:425–426PubMedPubMedCentralGoogle Scholar
  88. 88.
    Lackner TE (1991) Interaction of dexamethasone with phenytoin. Pharmacotherapy 11:344–347PubMedPubMedCentralGoogle Scholar
  89. 89.
    Pursche S, Schleyer E, von Bonin M et al (2008) Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients. Curr Clin Pharmacol 3:198–203PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Raymond E, Brandes AA, Dittrich C et al (2008) Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study. J Clin Oncol 26:4659–4665PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Wen PY, Yung WK, Lamborn KR et al (2006) Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res 12:4899–4907PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Maschio M, Dinapoli L, Sperati F et al (2011) Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neurooncol 104:205–214PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Usery JB, Michael LM II, Sills AK, Finch CK (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 99:251–260PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Kerkhof M, Dielemans JC, van Breemen MS et al (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol 15:961–967PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Maschio M, Zarabla A, Maialetti A et al (2017) Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: a prospective explorative study with a historical control group. Epilepsy Behav 73:83–89PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Maschio M, Dinapoli L, Mingoia M et al (2011) Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol 258:2100–2104PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Brodie MJ, Whitesides J, Schiemann J, D’Souza J, Johnson ME (2016) Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: a pooled analysis from three phase III studies. Epilepsy Res 127:114–118PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Moseley BD, Sperling MR, Asadi-Pooya AA et al (2016) Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: pooled results from three phase III studies. Epilepsy Res 127:179–185PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Elger C, Koepp M, Trinka E et al (2017) Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: data from four double-blind placebo-controlled pivotal phase III clinical studies. CNS Neurosci Ther 23:961–972PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Plosker GL (2012) Perampanel: as adjunctive therapy in patients with partial-onset seizures. CNS Drugs 26:1085–1096PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    French JA, Krauss GL, Biton V et al (2012) Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 79:589–596PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    French JA, Krauss GL, Steinhoff BJ et al (2013) Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia 54:117–125PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Krauss GL, Serratosa JM, Villanueva V et al (2012) Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78:1408–1415PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Van Nifterik KA, Van den Berg J, Slotman BJ, Lafleur MV, Sminia P, Stalpers LJ (2012) Valproic acid sensitizes human glioma cells for temozolomide and gamma-radiation. J Neurooncol 107:61–67PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Hosein AN, Lim YC, Day B et al (2015) The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells. J Neurooncol 122:263–271PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Chie EK, Shin JH, Kim JH, Kim HJ, Kim IA, Kim IH (2015) In vitro and in vivo radiosensitizing effect of valproic acid on fractionated irradiation. Cancer Res Treat 47:527–533PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Weller M, Gorlia T, Cairncross JG et al (2011) Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 77:1156–1164PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Barker CA, Bishop AJ, Chang M, Beal K, Chan TA (2013) Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86:504–509PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Happold C, Gorlia T, Chinot O et al (2016) Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol 34:731–739PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Bobustuc GC, Baker CH, Limaye A et al (2010) Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol 12:917–927PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Kim YH, Kim T, Joo JD et al (2015) Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer 121:2926–2932PubMedCrossRefPubMedCentralGoogle Scholar

via Epilepsy and Anticonvulsant Therapy in Brain Tumor Patients | SpringerLink

, , , , , , , ,

Leave a comment

[Book Chapter] Pregnancy and Epilepsy

VD Kapadia – Medical Disorders in Pregnancy

Epilepsy is the most common neurological disorder, with 50 million people affected by it worldwide. Nearly 50% of these affected individuals are women. The burden of  epilepsy in women in India is to the tune of 2.73 million, with 52% of them being in …

Continue —> Pregnancy and Epilepsy [PDF]

 

,

Leave a comment

[Manual] ICF – International Classification of Functioning, Disability and Health – PDF File

1. Background

This volume contains the International Classification of Functioning, Disability and Health, known as ICF.1 The overall aim of the ICF classification is to provide a unified and standard language and framework for the description of health and health-related states. It defines components of health and some health-related components of well-being (such as education and labour). The domains contained in ICF can, therefore, be seen as health domains and healthrelated domains. These domains are described from the perspective of the body, the individual and society in two basic lists: (1) Body Functions and Structures; and (2) Activities and Participation. 2 As a classification, ICF systematically groups different domains3 for a person in a given health condition (e.g. what a person with a disease or disorder does do or can do). Functioning is an umbrella term encompassing all body functions, activities and participation; similarly, disability serves as an umbrella term for impairments, activity limitations or participation restrictions. ICF also lists environmental factors that interact with all these constructs. In this way, it enables the user to record useful profiles of individuals’ functioning, disability and health in various domains.

ICF belongs to the “family” of international classifications developed by the World Health Organization (WHO) for application to various aspects of health. The WHO family of international classifications provides a framework to code a wide range of information about health (e.g. diagnosis, functioning and disability, reasons for contact with health services) and uses a standardized common language permitting communication about health and health care across the world in various disciplines and sciences. […]

Download PDF File

, , , , , , , , ,

Leave a comment

[BOOK] The Comorbidities of Epilepsy – Google Books

The Comorbidities of Epilepsy

Front Cover
Marco Mula
Academic PressApr 20, 2019 – Medical – 413 pages

Epilepsy is one of most frequent neurological disorders affecting about 50 million people worldwide and 50% of them have at least another medical problem in comorbidity; sometimes this is a the cause of the epilepsy itself or it is due to shared neurobiological links between epilepsy and other medical conditions; other times it is a long-term consequence of the antiepileptic drug treatment.

The Comorbidities of Epilepsy offers an up-to-date, comprehensive overview of all comorbidities of epilepsy (somatic, neurological and behavioral), by international authorities in the field of clinical epileptology, with an emphasis on epidemiology, pathophysiology, diagnosis and management. This book includes also a critical appraisal of the methodological aspects and limitations of current research on this field. Pharmacological issues in the management of comorbidities are discussed, providing information on drug dosages, side effects and interactions, in order to enable the reader to manage these patients safely.

The Comorbidities of Epilepsy is aimed at all health professionals dealing with people with epilepsy including neurologists, epileptologists, psychiatrists, clinical psychologists, epilepsy specialist nurses and clinical researchers.

  • Provides a comprehensive overview of somatic, neurological and behavioral co-morbidities of epilepsy
  • Discusses up-to-date management of comorbidities of epilepsy
  • Written by a group of international experts in the field

 

via The Comorbidities of Epilepsy – Google Books

, , , , ,

Leave a comment

[BLOG POST] 10 brain books you should read in 2019

Brain Changer: The Good Mental Health Diet by [Jacka, Felice]

What’s on your “to-read” list this year?

Here are a few books that I’ve read (or plan to in 2019) chosen based on research rigour, chosen, publication date (the last year or two) and practical application. In other words: these books synthesise the most compelling brain science and smart ideas emerging from the research lab and make it relevant for our everyday lives.

Have fun exploring big topics like how our emotions are created, the importance of gut health, the latest on habit formation, understanding the teenage brain, epigenetics, mindfulness, depression and anxiety and the female brain. Happy reading!

1. Brain Changer by Professor Felice Jacka

How is our brain and mental health affected by what we eat? Australian scientist, Felice Jacka uncovers the link between obesity and depression, how gut health impacts brain health and how a Mediterranean diet can keep our brains healthy as we age.

2. The Neuroscience of Mindfulness by Dr Stan Rodski

Where is the proof that mindfulness works? Discover the neuroscience behind mindfulness as Dr Rodski explains how being in the moment can lower stress, increase energy levels, build resilience and protect us from a range of life-threatening illnesses.

3. Mind-Brain-Gene by Dr John Arden

In this groundbreaking book, Arden explores the fascinating world of epigenetics, the immune system and mental health. He takes us on a fascinating journey into the mind-brain-body feedback loops, showing how they influence mental and physical health.

4. Inventing Ourselves by Professor Sarah-Jayne Blakemore

Blakemore, often credited with pioneering adolescent neurosciences, takes us on a tour through the groundbreaking science behind the enigmatic, but crucial, brain developments of adolescence and how those translate into teenage behaviour. Blakemore demystifies this period of development, outlining what makes the teenage brain unique and why mental illness can develop in these years.

5. Lost Connections by Johann Hari

In his bold and inspiring book, Hari goes on a quest to explore nine different causes of depression and anxiety including disconnection from meaningful work, other people, the natural world and hope. He challenges what we have believed to be true about depression and anxiety and their unexpected solution – reconnection.

6. Atomic Habits by James Clear

How do we create habits that stick? In his book, Clear explores the neuroscience of habit formation, along with proven principles in biology and psychology to offer an effective system for change. According to Clear, it’s the small changes made consistently which compound into life-changing results.

7. How Emotions Are Made by Professor Lisa Feldman Barrett

Barrett shakes up what we have previously thought true about how emotions are created. She challenges the idea that emotions are automatic and hard-wired in certain parts of the brain, using the latest in emotion science to show how emotion is actually created from a complex interplay between our brain, body and culture.

8. From the Laboratory to the Classroom by editors Jared Cooney Horvath, Jason M. Lodge and John Hattie

Are we applying what we know about the neuroscience of learning in the classroom? Horvath’s book combines theory and practice exceptionally well, offering useful strategies based on the science of learning, motivation, attention and memory.

9. Every Note Ever Played by Dr Lisa Genova

From neuroscientist and author of Still Alice, Genova’s latest novel is compelling and thought-provoking. She explores what it means to be truly alive, looking at the way neurological conditions impact identity and relationships. Genova is gifted at bringing to life the struggles experienced by those living with a neurological condition and those who love and care for them.

10. The Women’s Brain Book by Dr Sarah McKay

Of course, how could I not include my own book on this list for must-reads of 2019! My book takes you on a journey through the female lifespan (from womb to tomb) and explores how how brains are shaped by the lives we live, and in turn how how lives are shaped by our neurobiology.

via 10 brain books you should read in 2019 – Your Brain Health

,

Leave a comment

[BOOK] The Field of Competence of Physical and Rehabilitation Medicine Physicians

 

The Field of Competence of Physical and Rehabilitation Medicine Physicians

by Paris Stylianides

Published 4 years ago

219 pages

“The Field of Competence of the Physical and Rehabilitation Medicine physicians” PART ONE European Union of Medical Specialists (UEMS) Section of Physical and Rehabilitation Medicine – Professional Practice Committee

 

 

, , , ,

Leave a comment

[BOOK] Person Centered Approach to Recovery in Medicine – Luigi Grassi – Google Books

Bibliographic information

via Person Centered Approach to Recovery in Medicine – Luigi Grassi – Google Books

, , , , , ,

Leave a comment

[BOOK] Handbook of Biomechatronics – Chapter 9: Upper Extremity Rehabilitation Robots: A Survey – Google Books

Handbook of Biomechatronics

Εξώφυλλο
Jacob Segil
Academic Press29 Νοε 2018 – 619 σελίδες

Handbook of Biomechatronics provides an introduction to biomechatronic design and an in-depth explanation of some of the most exciting and groundbreaking biomechatronic devices in the world. Edited by Dr. Jacob Segil and written by a strong team of biomechatronics experts, the book covers biomechatronic design, components, and specific biomechatronic devices that span many disciplines. Sections cover sensors, actuators, processing and control systems, and signal processing. In addition, a chapter on biomechatronic devices contains distinct examples, spanning hearing aids to brain-machine interfaces. Each chapter presents the development phase of a biomechatronic device that is followed by an in-depth discussion of the current state-of-the-art.

  • Covers biomechatronic design, components and devices in one comprehensive source
  • Accessible for readers in multiple areas of study, such as bioengineering, computer science, electrical engineering, mechanical engineering and chemical engineering
  • Includes the most recent and groundbreaking advances in the biomechatronics field

Chapter 9: Upper Extremity Rehabilitation Robots: A Survey

, , , , , ,

Leave a comment

[BOOK] 22 ANNUAL CONFERENCE OF THE INTERNATIONAL FUCTIONAL ELECTRICAL STIMULATION SOCIETY – Abstracts

Enhancing quality of life
through electrical stimulation technology

22. ANNUAL CONFERENCE OF THE
INTERNATIONAL FUNCTIONAL
ELECTRICAL STIMULATION SOCIETY

All of the abstracts presented are available on line at http://ifess2018.com/down/IFESS2018_program.pdf

 

 

 

, , , , ,

Leave a comment

%d bloggers like this: